Loading…
Reported covered position: Legislative Aid, Senator Thad Cochran
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Safeguarding America's Pharmaceuticals Act of 2013
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 1919, S. 959, S. 957)
Protecting Seniors' Access to Medicare Act of 2013
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
MERCK & CO INC via MERCK & CO, INC.
2013 · first_quarter · 1A
Deficit reduction (no specific bill); ADAP funding (no specific bill)
Access to over-the-counter medications (no specific bill); compounding (no specific bill)
Source: Senate LDA
Protecting Seniors' Access to Medicare Act of 2013
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Protecting Seniors' Access to Medicare Act of 2013
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Protecting Seniors' Access to Medicare Act of 2013
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Protecting Seniors' Access to Medicare Act of 2013
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Protecting Seniors' Access to Medicare Act of 2013
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Supply chain safety (H.R. 1919, S. 959, S. 957)
Pharmaceutical Quality, Security, and Accountability Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 1919, S. 959, S. 957)
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Prescription Drug User Fee Act (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill)
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Generating Antibiotic Incentives Now Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (H.R. 3381); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Preserving Access to Life-Saving Medications Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187)
Preserving Access to Life-Saving Medications Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Preserving Access to Life-Saving Medications Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Hepatitis C education (H.R. 3381); Alzheimer's education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (H.R. 3381); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Food and Drug Administration Reform Act of 2012
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187)
Food and Drug Administration Reform Act of 2012
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Food and Drug Administration Reform Act of 2012
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Food and Drug Administration Reform Act of 2012
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Food and Drug Administration Reform Act of 2012
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (H.R. 3381); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Tort Reform (H.R. 5)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Antibiotic use in animals (HR 965/S.1211); prescription requirement for animal medications (HR 1406 )
Antibiotic use in animals (HR 965/S.1211); prescription requirement for animal medications (HR 1406 )
Business Transparency on Trafficking and Slavery Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Tort reform (H.R. 5); human trafficking (H.R. 2759)
Business Transparency on Trafficking and Slavery Act
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Tort reform (H.R. 5); human trafficking (H.R. 2759)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Medicare Decisions Accountability Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Antibiotic use in animals (HR 965/S.1211); prescription requirement for animal medications (HR 1406 )
Preservation of Antibiotics for Medical Treatment Act of 2011
Client: MERCK & CO INC · Firm: MERCK & CO, INC.
Antibiotic use in animals (HR 965/S.1211); prescription requirement for animal medications (HR 1406 )
Tort reform (H.R. 5); human trafficking (H.R. 2759)
Tort reform (H.R. 5); human trafficking (H.R. 2759)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Patent settlements (no specific bill)
Alzheimer's education (no specific bill); 340b (no specific bill); hepatitis C education (no specific bill).
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
Supply chain safety (no specific bills)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2013 · second_quarter · Q2
Supply chain safety (H.R. 1919, S. 959, S. 957)
Patent settlements (no specific bill)
Alzheimer's education (no specific bill); 340b (no specific bill); maternal health education (no specific bill).
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
Access to over-the-counter medications (no specific bill); compounding (no specific bill)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Deficit reduction (no specific bill); ADAP funding (no specific bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2013 · first_quarter · Q1
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (S. 351, H.R. 351)
Alzheimer's education (no specific bill); 340b (no specific bill); hepatitis C education (no specific bill).
Access to over-the-counter medications (no specific bill); compounding (no specific bill)
Patent settlements (no specific bill)
Deficit reduction (no specific bill); ADAP funding (no specific bill)
Supply chain safety (no specific bills)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2012 · fourth_quarter · Q4
Deficit reduction (no specific bill); ADAP funding (no specific bill)
Hepatitis C education (H.R. 3381); Alzheimer's education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Great Apes (S. 810)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Access to over-the-counter medications (no specific bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MERCK & CO INC via MERCK & CO, INC.
2012 · third_quarter · Q3
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (H.R. 3381); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Deficit reduction (no specific bill); ADAP funding (no specific bill)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
Great Apes (S. 810)
Access to over-the-counter medications (no specific bill)
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187; H.R. 3381)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
MERCK & CO INC via MERCK & CO, INC.
2012 · second_quarter · Q2
Supply chain safety (H.R. 5651; S. 3187); pharmaceutical shortages (H.R. 2245; S. 296;H.R. 5651; S. 3187)
Reauthorization of the Prescription Drug User Fee Act (H.R. 5651; S. 3187); incentives for antibiotic research and development (H.R. 2182; H.R. 5651; S. 3187); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill).
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
MERCK & CO INC via MERCK & CO, INC.
2012 · first_quarter · Q1
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, H.R. 5, S. 668)
Prescription Drug User Fee Act (no specific bill); incentives for antibiotic research and development (H.R. 2182); hepatitis C education (no specific bill); improvements to vaccine immunization (no specific bill); 340b (no specific bill)
Tort Reform (H.R. 5)
MERCK & CO INC via MERCK & CO, INC.
2011 · fourth_quarter · Q4
Tort reform (H.R. 5); human trafficking (H.R. 2759)
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Access to over-the-counter medications (no specific bill)
MERCK & CO INC via MERCK & CO, INC.
2011 · third_quarter · Q3
Non-interference in Medicare Part D (no specific bill); Medicaid-style rebates in Medicare Part D (no specific bill); Independent Payment Advisory Board (H.R. 452, S. 668)
Patent Reform (H.R. 1249)
Access to over-the-counter medications (no specific bill)
Access to over-the-counter medications (no specific bill)
Comprehensive tax reform (no specific bill); transfer pricing of intangibles (no specific bill); territorial tax system (no specific bill); deferral of taxation of foreign earned income (no specific bill); tax base erosion (no specific bill).
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Access to over-the-counter medications (no specific bill)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Deficit Reduction (no specific bill)
Antibiotic use in animals (HR 965/S.1211); prescription requirement for animal medications (HR 1406 )
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, U.S. Trade Representative (USTR)
Tort reform (H.R. 5); human trafficking (H.R. 2759)
Antibiotic use in animals (HR 965/S.1211); prescription requirement for animal medications (HR 1406 )
Deficit Reduction (no specific bill); WTO Cotton Agreement (H.R. 2112)
Filing targets: HOUSE OF REPRESENTATIVES, SENATE